10
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T64162 | AChE-IN-5 | ||
AChE-IN-5 (compound 5) 是一种口服具有活力的、能够透过血脑屏障的、对 AChE/5-HT1A/SERT 具有显著的体外生物活性的物质。AChE-IN-5 能够作用于 AChE (IC50: 2.29 nM)、5-HT1A (EC50: 58.6 nM)、SERT (IC50: 2.29 nM)。 | |||
T60721 |
AChE/BChE-IN-5
|
||
AChE/BChE-IN-5 (BMC-16) 是AChE 和BChE 的双重抑制剂,可以透过血脑屏障。AChE/BChE-IN-5 对人 AChE (hAChE) 和BChE (hBChE) 的IC50值分别为 266 nM 和 10.6 nM。 | |||
T72893 |
AChE/MAO-IN-2
|
||
Dual AChE-MAO B-IN-5 是一种茚满酮衍生物,是一种有效的双重 AChE/MAO-B 抑制剂,对 AChE、MAO-B 和 MAO-A 的IC50值分别为 0.0224、0.0412 和 0.1116 μM。Dual AChE-MAO B-IN-5 具有抗氧化活性,防止 β-淀粉样斑块聚集。Dual AChE-MAO B-IN-5 可用于阿尔茨海默病 (AD) 研究。 | |||
T61178 |
Aβ-IN-5
|
||
Aβ-IN-5 (Compound e12) is an orally active Aβ aggregation inhibitor that also inhibits AChE and BuChE with IC50 values of 21.29 μM and 1.32 μM, respectively. Furthermore, Aβ-IN-5 exhibits remarkable neuroprotective effects along with low neurotoxicity [1]. | |||
T62046 |
HDAC6-IN-5
|
||
HDAC6-IN-5 (化合物 11b) 是有效的、血脑屏障通透性的 HDAC6抑制剂(IC50= 0.025 μM)。HDAC6-IN-5 抑制 AChE 活性和 Aβ1-42自聚集和,IC50分别为 0.88 和 1.1 μM。HDAC6-IN-5 能够促进神经突起生长,且无明显神经毒性。 | |||
T64102 | hCAI/II-IN-5 | ||
hCAI/II-IN-5 是 hCA I 和 hCA II (人碳酸酐酶同工酶 I 和 II) 的有效抑制剂,他们的IC50值分别为 37.88 和 45.23 nM。 hCAI/II-IN-5 也能够抑制 α-Glycosidase (IC50: 48.98 nM) 和 AChE (IC50: 420.14 nM)。hCAI/II-IN-5 能够用于研究糖尿病、心力衰竭、阿尔茨海默病、溃疡、癫痫等多种疾病。 | |||
T63215 |
COX-2-IN-22
|
||
COX-2-IN-22 是一种能够透过血脑屏障的 COX-2 抑制剂 (IC50: 8.6 μM),也对AChE (IC50: 2.8 μM)、BChE (IC50: 6.3 μM)、β-Secretase (IC50: 15.3 μM)、LOX-5 (IC50: 13.9 μM) 和 DPPH (IC50: 6.8 μM)表现出抑制作用。 | |||
T36639 | Donecopride (fumarate hydrate) | ||
Donecopride is a partial agonist of the serotonin (5-HT) receptor subtype 5-HT4E(Ki= 8.5 nM) and an inhibitor of acetylcholinesterase (AChE; IC50= 16 nM).1It is selective for AChE over butyrylcholinesterase (BChE; IC50= 3,530 nM) but does bind to 5-HT2Band sigma-2 (σ2) receptors (Ki= 1.6 nM for both) in a panel of 42 neurotransmitter receptors and transporters. Donecopride induces release of soluble amyloid precursor protein-α (sAPP-α) in COS-7 cells transiently expressing 5-HT4with an EC50value... | |||
T35975 |
6,9-Dichloro-1,2,3,4-tetrahydroacridine
|
||
6,9-Dichloro-1,2,3,4-tetrahydroacridine is a synthetic intermediate in the synthesis of tacrine-based acetylcholinesterase (AChE) inhibitors.1It is also an intermediate in the synthesis of multifunctional tacrine hybrids that possess radical scavenging, amyloid-β aggregation inhibitory, and/or β-secretase 1 (BACE1) inhibitory activities in addition to their activity as AChE inhibitors.2,3 1.Recanatini, M., Cavalli, A., Belluti, F., et al.SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylchol... | |||
T73930 |
(-)-Eseroline fumarate
|
||
(-)-Eseroline fumarate 是一种 AChE 抑制剂 Physostigmine 的代谢产物。(-)-Eseroline fumarate 引起癌细胞的乳酸脱氢酶 (LDH) 泄漏。(-)-Eseroline fumarate 还诱导神经元细胞释放腺嘌呤核苷酸和5-羟色胺 (5-HT),从而诱导细胞死亡。(-)-Eseroline fumarate 抑制小鼠输精管和豚鼠回肠的电诱发抽搐。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5S2343 |
Acetylshikonin
乙酰紫草素,Acetyl shikonin |
Others; P450; AChE | Metabolism; Neuroscience; Others |
Acetylshikonin 来源于紫草根,具有抗癌、抗炎作用。它是一种 AChE 抑制剂,具有很强的抗凋亡活性。它是一种非选择性的细胞色素 P450抑制剂,对所有 P450 亚型抑制的 IC50值范围为 1.4-4.0 μM。 | |||
T4700 |
1,3,5-Trihydroxy-4-prenylxanthone
|
||
1,3,5-Trihydroxy-4-prenylxanthone is a relatively potent inhibitor of phosphodiesterase type 5 (PDE5), with an IC50 value of 3.0 μM; it shows in vitro inhibitory activity against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), with IC50 valu |